Can FDA Keep Up With Evolving Artificial Intelligence Field? New Oversight Methods Are Being Developed, Gottlieb Says

Outgoing FDA Commissioner Scott Gottlieb said changes might involve a "more tailored fit'' to examine a product’s algorithms, a manufacturer’s plan to make modifications and ability to manage any risks. Other technology news focuses on electronic health records projects at the VA and elsewhere.

from Kaiser Health News https://ift.tt/2HU7Sl1